Non-participation in systematic screening for osteoporosis-the ROSE trial.

about

Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.

P2860

Q47582702-B0A7EA0F-A497-41AF-8E86-B4B4E1D94972

P2860

Non-participation in systematic screening for osteoporosis-the ROSE trial.

Item

http://www.wikidata.org/entity/Q42688101

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Non-participation in systematic screening for osteoporosis-the ROSE trial.

@en

Non-participation in systematic screening for osteoporosis-the ROSE trial.

@nl

type

Item

label

Non-participation in systematic screening for osteoporosis-the ROSE trial.

@en

Non-participation in systematic screening for osteoporosis-the ROSE trial.

@nl

prefLabel

Non-participation in systematic screening for osteoporosis-the ROSE trial.

@en

Non-participation in systematic screening for osteoporosis-the ROSE trial.

@nl

P1476

Non-participation in systematic screening for osteoporosis-the ROSE trial.

@en

P2093

A P Hermann

http://www.w3.org/2001/XMLSchema#string

C-C Glüer

http://www.w3.org/2001/XMLSchema#string

J Gram

http://www.w3.org/2001/XMLSchema#string

K Brixen

http://www.w3.org/2001/XMLSchema#string

M Højberg

http://www.w3.org/2001/XMLSchema#string

R Barkmann

http://www.w3.org/2001/XMLSchema#string

T Holmberg

http://www.w3.org/2001/XMLSchema#string

P2860

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Recognizing and treating secondary osteoporosis

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision.

Socioeconomic position and participation in colorectal cancer screening.

Identifying specific non-attending groups in breast cancer screening--population-based registry study of participation and socio-demography.

Participation rate or informed choice? Rethinking the European key performance indicators for mammography screening.

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

Adherence of academic geriatric practitioners to osteoporosis screening guidelines.

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle.

P2888

s00198-017-4205-y

P304

3389-3399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-017-4205-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091499100

http://www.w3.org/2001/XMLSchema#string

P698

28875257

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

Non-participation in systematic screening for osteoporosis-the ROSE trial.

about

P2860

P2860

Non-participation in systematic screening for osteoporosis-the ROSE trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921